Research Article
Valuable Serum Markers in Pulmonary Alveolar Proteinosis
Table 3
Comparison of DLCO-SB and other parameters before and after inhalation of the GM-CSF treatment in PAP patients.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compared with before GM-CSF treatment, a. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Compared with before GM-CSF treatment, a. |